Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $123.52 million. The enterprise value is $139.04 million.
Important Dates
The next estimated earnings date is Tuesday, March 10, 2026, after market close.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 15.99 million shares outstanding. The number of shares has increased by 89.19% in one year.
| Current Share Class | 15.99M |
| Shares Outstanding | 15.99M |
| Shares Change (YoY) | +89.19% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 31.33% |
| Owned by Institutions (%) | 14.00% |
| Float | 6.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.22 |
| Forward PS | 4.99 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.25
| Current Ratio | 1.25 |
| Quick Ratio | 0.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.77 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -26.28% |
| Return on Invested Capital (ROIC) | -61.09% |
| Return on Capital Employed (ROCE) | -129.46% |
| Revenue Per Employee | $434,211 |
| Profits Per Employee | -$366,394 |
| Employee Count | 71 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 4.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.50% in the last 52 weeks. The beta is 1.46, so VRCA's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | +8.50% |
| 50-Day Moving Average | 7.08 |
| 200-Day Moving Average | 5.84 |
| Relative Strength Index (RSI) | 49.91 |
| Average Volume (20 Days) | 186,743 |
Short Selling Information
The latest short interest is 292,263, so 1.83% of the outstanding shares have been sold short.
| Short Interest | 292,263 |
| Short Previous Month | 380,561 |
| Short % of Shares Out | 1.83% |
| Short % of Float | 4.36% |
| Short Ratio (days to cover) | 1.18 |
Income Statement
In the last 12 months, VRCA had revenue of $30.83 million and -$26.01 million in losses. Loss per share was -$2.96.
| Revenue | 30.83M |
| Gross Profit | 20.66M |
| Operating Income | -15.52M |
| Pretax Income | -26.01M |
| Net Income | -26.01M |
| EBITDA | -14.96M |
| EBIT | -15.52M |
| Loss Per Share | -$2.96 |
Full Income StatementBalance Sheet
The company has $21.10 million in cash and $35.74 million in debt, with a net cash position of -$14.64 million or -$0.92 per share.
| Cash & Cash Equivalents | 21.10M |
| Total Debt | 35.74M |
| Net Cash | -14.64M |
| Net Cash Per Share | -$0.92 |
| Equity (Book Value) | -17.04M |
| Book Value Per Share | -1.80 |
| Working Capital | 7.37M |
Full Balance SheetCash Flow
| Operating Cash Flow | -29.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | -29.10M |
| FCF Per Share | -$1.82 |
Full Cash Flow StatementMargins
Gross margin is 67.02%, with operating and profit margins of -50.34% and -84.38%.
| Gross Margin | 67.02% |
| Operating Margin | -50.34% |
| Pretax Margin | -84.38% |
| Profit Margin | -84.38% |
| EBITDA Margin | -48.52% |
| EBIT Margin | -50.34% |
| FCF Margin | n/a |
Dividends & Yields
VRCA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -89.19% |
| Shareholder Yield | -89.19% |
| Earnings Yield | -20.91% |
| FCF Yield | -23.39% |
Analyst Forecast
The average price target for VRCA is $17.00, which is 120.07% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.00 |
| Price Target Difference | 120.07% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 77.18% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 25, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
VRCA has an Altman Z-Score of -10.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.53 |
| Piotroski F-Score | 3 |
